People News

Share this article:

Oriel Therapeutics, a specialty pharma concentrated on respiratory care, has appointed Richard Fuller as CEO, effective immediately. Fuller was formerly a senior executive at GlaxoSmithKline, and was most recently executive vice president of research and development at Aerovance.

 
TheraGenetics Limited, a personalized medicine diagnostics company, has appointed Robert McBurney to executive vice president.  McBurney will report to Richard Kivel, CEO of TheraGenetics.

 
Curemark, a biotech focused on the treatment of neurological and other diseases, has appointed Elisa Zinberg as vice president of operations. Zinberg was previously COO of The Masters Circle, a health care consulting company.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.